• 751 static and 225 outreach HIV testing sites
• 730 (static) ART sites; 615 of these started at least one pregnant or breastfeeding woman and 699 started asymptomatic patients (Test & Treat) this quarter
• 660 sites with HIV-exposed children in follow-up

1,018,328 persons were tested for HIV and received their results; 277,861 (27%) accessed HIV testing for the first time; 740,467 (73 %) were repeat testers and 43,905 (4%) of these received confirmatory testing (after having tested positive in the past). 37,562 (4%) clients received a positive result for the first time.

21,480 (99%) of 21,653 blood units collected were screened for (at least) HIV, hepatitis B and syphilis.

148,638 (97%) of 153,348 women at ANC had their HIV status ascertained; 11,356 (7%) of these were HIV positive. 135,778 (99%) of 137,339 women at maternity had their HIV status ascertained 9,819 (7%) of these were HIV positive.

32,573 patients started ART this quarter; 75% of these were classified as asymptomatic / in WHO stage 1 and started under the new “Test & Treat” policy.

714,691 patients were alive and on ART by end of June 2017. This means that 69% of the estimated 1,035,000 HIV positive population was on ART. 1 ART coverage was 54% (54,573 / 101,000) for children and 71% (660,117 / 932,000) for adults.

51,414 (86%) of 57,900 viral load results from routine monitoring were <1000 copies/ml. Viral suppression rates for routine samples among children (0-14 years) and adults (15+ years) were 78% and 95%, respectively.

77% of adults and 77% of children were retained alive on ART at 12 months after initiation. Actual retention rates are thought to be about 10% higher due to misclassification of ‘silent transfers’ as defaulters in clinic-based survival/retention analysis. (see section 14.4)

620,433 (93%) of 696,400 patients on first line adult ART were on TDF/3TC/EFV.

12,048 (91%) of an estimated 13,250 HIV infected pregnant women in Malawi were on ART this quarter. 7,993 (66%) of these were already on ART when getting pregnant and 4,055 (34%) started ART during pregnancy/delivery.

An additional 1,390 breastfeeding women started ART in WHO stage 1 or 2.

80%, 75%, 69% and 65% of women started while pregnant or breastfeeding were retained on ART at 6, 12, 24 and 36 months after initiation, respectively.

9,041 (7%) of infants discharged alive from maternity were known to be HIV exposed, 8,677 (96%) of these received ARV prophylaxis (nevirapine). 10,149 were enrolled in exposed child follow-up before age 2 months.

A total of 13,335 HIV exposed children were newly enrolled for follow-up this quarter.